These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 15839373)

  • 1. Immunosuppressant strategies for intestinal transplantation: a review of a tolerogenic regimen.
    Flynn B; Park BK; Bond G; McGhee W; Mazariegos G; Sindhi R; Reyes J; Abu-Elmagd K
    Prog Transplant; 2005 Mar; 15(1):60-4. PubMed ID: 15839373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolutionary experience with immunosuppression in pediatric intestinal transplantation.
    Bond GJ; Mazariegos GV; Sindhi R; Abu-Elmagd KM; Reyes J
    J Pediatr Surg; 2005 Jan; 40(1):274-9; discussion 279-80. PubMed ID: 15868597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical intestinal transplantation: a decade of experience at a single center.
    Abu-Elmagd K; Reyes J; Bond G; Mazariegos G; Wu T; Murase N; Sindhi R; Martin D; Colangelo J; Zak M; Janson D; Ezzelarab M; Dvorchik I; Parizhskaya M; Deutsch M; Demetris A; Fung J; Starzl TE
    Ann Surg; 2001 Sep; 234(3):404-16; discussion 416-7. PubMed ID: 11524593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A decade of experience with a single dose of rabbit antithymocyte globulin or alemtuzumab pretreatment for intestinal and multivisceral transplantation.
    Abu-Elmagd KM; Costa G; Bond GJ; Soltys K; Martin L; Koritsky DA; Cunha-Melo JR; Sogawa H; Irish W; Tzakis A; Mazariegos G
    Clin Transpl; 2012; ():155-66. PubMed ID: 23721018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of the immunosuppressive strategies for the intestinal and multivisceral recipients with special reference to allograft immunity and achievement of partial tolerance.
    Abu-Elmagd KM; Costa G; Bond GJ; Wu T; Murase N; Zeevi A; Simmons R; Soltys K; Sindhi R; Stein W; Demetris A; Mazariegos G
    Transpl Int; 2009 Jan; 22(1):96-109. PubMed ID: 18954362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on Maintenance Immunosuppression in Intestinal Transplantation.
    Patwardhan S; Hong J; Weiner J
    Gastroenterol Clin North Am; 2024 Sep; 53(3):493-507. PubMed ID: 39068010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal and multivisceral transplantation immunosuppression protocols--literature review.
    Trevizol AP; David AI; Dias ER; Mantovani D; Pécora R; D'Albuquerque LA
    Transplant Proc; 2012 Oct; 44(8):2445-8. PubMed ID: 23026616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Indications and results of small bowel transplantation in adults].
    Joly F; Panis Y
    Bull Acad Natl Med; 2012 Feb; 196(2):393-404. PubMed ID: 23420959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intestinal transplantation: evolution in immunosuppression protocols.
    Pirenne J; Kawai M
    Curr Opin Organ Transplant; 2009 Jun; 14(3):250-5. PubMed ID: 19373085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcineurin inhibitor-free immunosuppression in pediatric renal transplantation: a viable option?
    Höcker B; Tönshoff B
    Paediatr Drugs; 2011 Feb; 13(1):49-69. PubMed ID: 21162600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Status of liver and gastrointestinal transplantation at the University of Miami.
    Weppler D; Khan R; Fragulidis GP; Nery JR; Ricordi C; Tzakis AG
    Clin Transpl; 1996; ():187-201. PubMed ID: 9286568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete freedom from rejection after intestinal transplantation using a new tolerogenic protocol combined with low immunosuppression.
    Pirenne J; Koshiba T; Geboes K; Emonds MP; Ferdinande P; Hiele M; Nevens F; Waer M
    Transplantation; 2002 Mar; 73(6):966-8. PubMed ID: 11923701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period.
    Zanfi C; Lauro A; Cescon M; Dazzi A; Ercolani G; Grazi GL; Zanello M; Vivarelli M; Del Gaudio M; Ravaioli M; Cucchetti A; Vetrone G; Tuci F; Di Gioia P; Lazzarotto T; D'Errico A; Bagni A; Faenza S; Siniscalchi A; Pironi L; Pinna AD
    Transplant Proc; 2010; 42(1):35-8. PubMed ID: 20172276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal and multivisceral transplantation.
    Moon JI; Tzakis AG
    Yonsei Med J; 2004 Dec; 45(6):1101-6. PubMed ID: 15627303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppression Protocols in Intestinal and Multivisceral Transplantation-A Literature Review.
    Ferreira MA; Ouverney LFF; Figueiredo MC; David AI
    Transplant Proc; 2023; 55(6):1431-1436. PubMed ID: 37088617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.
    Woodroffe R; Yao GL; Meads C; Bayliss S; Ready A; Raftery J; Taylor RS
    Health Technol Assess; 2005 May; 9(21):1-179, iii-iv. PubMed ID: 15899149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal and multivisceral transplantation: future perspectives.
    Selvaggi G; Tzakis AG
    Front Biosci; 2007 May; 12():4742-54. PubMed ID: 17485410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term outcomes and quality of life after intestine transplantation.
    Sudan D
    Curr Opin Organ Transplant; 2010 Jun; 15(3):357-60. PubMed ID: 20445450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fifteen years' experience of intestinal and multivisceral transplantation in the Nordic countries.
    Varkey J; Simrén M; Jalanko H; Oltean M; Saalman R; Gudjonsdottir A; Gäbel M; Borg H; Edenholm M; Bentdal O; Husby S; Staun M; Mäkisalo H; Bosaeus I; Olausson M; Pakarinen M; Herlenius G
    Scand J Gastroenterol; 2015 Mar; 50(3):278-90. PubMed ID: 25592555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome after intestinal transplantation: results from one center's 9-year experience; discussion 1031-2.
    Farmer DG; McDiarmid SV; Yersiz H; Cortina G; Amersi F; Vargas J; Gershman G; Ament M; Busuttil RW
    Arch Surg; 2001 Sep; 136(9):1027-31. PubMed ID: 11529825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.